-
Mashup Score: 3First-in-Class Bicycle Toxin Conjugate Targeting Nectin-4 Generates Excitement in Urothelial Carcinoma - 2 month(s) ago
Oncologists detail how zelenectide pevedotin, which is under evaluation in the Duravelo-2 trial, could fill an unmet need in metastatic urothelial carcinoma.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 3JAK Inhibitors Remain the Gold Standard in Myelofibrosis - 2 month(s) ago
Daniel DeAngelo MD, PhD, discusses the incorporation of JAK inhibitors into the myelofibrosis treatment paradigm.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
JAK Inhibitors Remain the Gold Standard in Myelofibrosis @DanaFarber #oncology #MedTwitter #MedEd https://t.co/JgkoQb7uKd
-
-
Mashup Score: 2
Daniel J. DeAngelo MD, PhD, discusses the potential role for INCA033989 as a disease-modifying therapy in CALR type 1–mutated myelofibrosis.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
INCA033989 May Address Need for Disease-Modifying Therapies in Myelofibrosis @DanaFarber #oncology #MedTwitter #MedEd https://t.co/XqWOGyyqaB
-
-
Mashup Score: 3First-in-Class Bicycle Toxin Conjugate Targeting Nectin-4 Generates Excitement in Urothelial Carcinoma - 2 month(s) ago
Oncologists detail how zelenectide pevedotin, which is under evaluation in the Duravelo-2 trial, could fill an unmet need in metastatic urothelial carcinoma.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
First-in-Class Bicycle Toxin Conjugate Targeting Nectin-4 Generates Excitement in Urothelial Carcinoma @DrTFriedlander @UCSFCancer @kalasri3 @thePMCF #oncology #MedTwitter #MedEd https://t.co/mf3jhWHT0E
-
-
Mashup Score: 2
Jorge Cortes, MD, inaugural editor-in-chief of Blood Global Hematology, details what type of research the new journal will highlight and its importance.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
New Global Hematology Journal Strives to Feature Innovative and Adaptable Research @GCC_Cortes @GACancerCenter #oncology #MedTwitter #MedEd https://t.co/FB2p71QumY
-
-
Mashup Score: 9PARP1-Selective Inhibitors Generate Excitement in Solid Tumors - 2 month(s) ago
Neeraj Agarwal, MD, FASCO; Andrew J. Armstrong, MD, MSc; and Timothy A. Yap, MBBS, PhD, FRCP, detail the latest research on PARP1-selective inhibitors in oncology.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
PARP1-Selective Inhibitors Generate Excitement in Solid Tumors @neerajaiims @HuntsmanCancer @AarmstrongDuke @DukeCancer @MDAndersonNews #oncology #MedTwitter #MedEd https://t.co/j6rGDmJ6ZD
-
First-in-Class Bicycle Toxin Conjugate Targeting Nectin-4 Generates Excitement in Urothelial Carcinoma @DrTFriedlander @UCSFCancer @kalasri3 @thePMCF #oncology #MedTwitter #MedEd https://t.co/mf3jhWHT0E